An Ischemic Stroke Related to Eltrombopag Use in a Patient with Idiopathic Thrombocytopenic Purpura
Abstract
Thrombopoetin receptor agonists like eltrombopag, used for Idiopathic Thrombocytopenic Purpura treatment rarely cause to the ischemic cerebrovascular disease. In this report, a patient, have been followed by ITP diagnosis for 5 years, admitted to the emergency service for right hemiparesis and aphasia. It was diagnosed as ischemic cerebrovascular disease. Etiology of patient’s cerebrovascular event was associated with eltrombopag. Because of this rare seen situation, it was argued by in the light of the literature.
Key words: Idiopathic thrombocytopenic purpura, thrombopoietin receptor agonist, eltrombopag, ischemic stroke
Keywords
References
- Chen YC, Wu JS, Yang ST, et al. Stroke, angiogenesis and
- phytochemicals. Front Biosci 2012; 4:599-610.
- Bussel JB, Cheng G, Saleh MN, et al: Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. New Engl J Med 2007; 357:2237-2247.
- Park HK, Lee SH. Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics. Neurol Sci 2014; 35:1801-1806
- Sarpatwari A, Bennett D, Logie JW, et al. Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database. Haematologica 2010; 95:1167-1175.
- Aoki T, Harada Y, Matsubara E, et al. Thrombopoietin receptor
- agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations. J Clin Pharm Theraps 2012; 37:729-732.
- Norgaard M: Thrombosis in patients with primary chronic immune thrombocytopenia. Thrombosis research. 2012;130:74-75.
Details
Primary Language
Turkish
Subjects
-
Journal Section
-
Publication Date
March 1, 2016
Submission Date
March 29, 2016
Acceptance Date
-
Published in Issue
Year 2016 Volume: 43 Number: 1